XML 78 R41.htm IDEA: XBRL DOCUMENT v3.23.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Share-based Compensation, Activity The following table presents our total stock-based compensation expense:
Year Ended
202220212020
Employee stock-based compensation expense
     Pre-tax (1)
$1,230 $875 $876 
     Post-tax (2)
972 691 692 
Director stock-based compensation expense
     Pre-tax (1)
158 310 506 
     Post-tax (2)
125 245 400 
(1) This table does not include withholding of vested shares for tax liabilities, which totaled $25,000, $39,000, and $112,000 in 2022, 2021, and 2020, respectively.
(2) The after tax amounts are determined using the 21% corporate federal tax rate.
Schedule of Nonvested Share Activity The following table presents certain information related to the activity of our non-vested common stock grants:
Number of Restricted SharesWeighted Average Grant Date Fair Value
Outstanding as of December 31, 2019214,495 $17.49 
Granted (1)
386,101 9.33 
Less: Forfeited232,323 12.61 
Less: Vested (1)
109,267 16.63 
Outstanding as of December 31, 2020
259,006 $10.06 
Granted292,960 6.01 
Less: Forfeited122,460 8.87 
Less: Vested92,910 9.99 
Outstanding as of December 31, 2021
336,596 $6.99 
Granted907,907 1.97 
Less: Forfeited
383,876 3.43 
Less: Vested146,388 6.00 
Outstanding as of December 31, 2022
714,239 $2.73 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The following weighted-average assumptions were used to value the stock options granted:
20222021
Expected annual dividend yield—  %0.65  %
Expected volatility49.66  %46.63  %
Risk-free interest rate2.92  %1.16  %
Expected term years years
Schedule of Share-based Compensation, Stock Options and Stock Appreciation Rights Award Activity The following table presents certain information related to the activity of our non-vested stock option grants:
Number of Stock OptionsWeighted Average Exercise PricesWeighted Average Remaining Contractual Term (years)Aggregate Intrinsic Value
Outstanding as of December 31, 2019207,069 $18.69 9.00 $— 
Granted221,541 8.77 — — 
Less: Forfeited234,472 12.76 — — 
Less: Exercised— — — — 
Less: Expired50,132 18.94 — — 
Outstanding as of December 31, 2020
144,006 $13.00 8.77 $— 
Vested as of December 31, 2020
80,728 $19.01 7.95 $— 
Exercisable as of December 31, 2020
30,596 $19.11 7.95 $— 
Outstanding as of December 31, 2020
144,006 $13.00 8.77 $— 
Granted1,054,707 3.86 — — 
Less: Forfeited48,995 8.08 — — 
Less: Exercised— — — — 
Less: Expired2,503 16.25 — — 
Outstanding as of December 31, 2021
1,147,215 $4.80 9.49 $792,000 
Vested as of December 31, 2021
120,638 $15.87 7.39 $— 
Exercisable as of December 31, 2021
68,003 $15.85 7.39 $— 
Outstanding as of December 31, 2021
1,147,215 $4.80 9.49 $792,000 
Granted635,643 1.70 — — 
Less: Forfeited426,480 2.91 — — 
Less: Exercised— — — — 
Less: Expired105,693 6.65 — — 
Outstanding as of December 31, 2022
1,250,685 $3.71 7.66 $— 
Vested as of December 31, 2022 (1)
532,797 $7.26 8.03 $— 
Exercisable as of December 31, 2022
432,786 $5.25 5.10 $—